Tokman Alexander Y has filed 4 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 26921 shares of ENDRA Life Sciences Inc. ($NDRA) on March 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | ENDRA Life Sciences Inc. | $NDRA | Tokman Alexander Y | Chief Executive Officer | A | Common Stock | 26921 | $0.00 | 101,926.0000 | 562,213 | 35.89% | 4.79% |
| Jan. 21, 2026 | ENDRA Life Sciences Inc. | $NDRA | Tokman Alexander Y | Chief Executive Officer | A | Common Stock | 75000 | $0.00 | 75,005.0000 | 562,213 | 9999.99% | 13.34% |
| Jan. 2, 2024 | ENDRA Life Sciences Inc. | $NDRA | Tokman Alexander Y | Director | A | Stock Options | 600 | $0.00 | 600.0000 | 0 | 9999.99% | 0.00% |
| Jan. 30, 2023 | ENDRA Life Sciences Inc. | $NDRA | Tokman Alexander Y | Director | A | Stock Options | 9621 | $0.00 | 9,621.0000 | 0 | 9999.99% | 0.00% |